38084360|t|Dolutegravir-induced acquired sideroblastic anemia in a HIV positive patient: A challenging hematologic complication.
38084360|a|Dolutegravir, the most recent antiretroviral drug with high efficacy, good tolerability, infrequent drug-drug interactions, and a favorable safety profile has not been reported in current literature as a cause of acquired sideroblastic anemia. Here, we present a 35-year-old male patient who was diagnosed with acquired sideroblastic anemia to Dolutegravir therapy.
38084360	0	12	Dolutegravir	Chemical	MESH:C562325
38084360	30	50	sideroblastic anemia	Disease	MESH:D000756
38084360	56	59	HIV	Species	11676
38084360	69	76	patient	Species	9606
38084360	92	116	hematologic complication	Disease	MESH:D011250
38084360	118	130	Dolutegravir	Chemical	MESH:C562325
38084360	340	360	sideroblastic anemia	Disease	MESH:D000756
38084360	398	405	patient	Species	9606
38084360	438	458	sideroblastic anemia	Disease	MESH:D000756
38084360	462	474	Dolutegravir	Chemical	MESH:C562325
38084360	Positive_Correlation	MESH:C562325	MESH:D000756

